Are we listening to everything the PARK genes are telling us?
Deanna L BensonGeorge W HuntleyPublished in: The Journal of comparative neurology (2019)
The cardinal motor symptoms that define Parkinson's disease (PD) clinically have been recognized for over 200 years. That these symptoms arise following the loss of dopamine neurons in the substantia nigra has been known for the last 50. These long-established facts have fueled a broadly held expectation that degenerating dopaminergic neurons alone hold the key to understanding and curing PD. This prevalent expectation is at odds with the observation that many nonmotor symptoms, including depression and cognitive inflexibility among others, can appear years earlier than the overt dopaminergic neuron degeneration that drives motor abnormalities and are not improved by levodopa treatment. Thus, preserving or rescuing dopamine neuron health and function is of paramount importance, but this alone fails to capture the underlying neurobiology of earlier-appearing nonmotor symptoms. Insight into the complete landscape of disease-related abnormalities and the context in which they arise can be gleaned from a more comprehensive consideration of the PARK genes that are known to cause PD. Here, we make the case that a full incorporation of research showing when and where PARK genes are expressed as well as the impact of gene mutation on function throughout life, in tandem with research studying how dopaminergic neuron degeneration begins, is essential for a full understanding of the multi-dimensional etiology of PD. A broad view may also reveal something about long-term adjustments cells and systems make in response to gene mutation and help to identify mechanisms conferring the resilience or susceptibility of some cells and systems over others.
Keyphrases
- genome wide
- induced apoptosis
- parkinson disease
- sleep quality
- spinal cord
- healthcare
- public health
- genome wide identification
- endoplasmic reticulum stress
- mental health
- dna methylation
- single cell
- depressive symptoms
- oxidative stress
- cell proliferation
- uric acid
- climate change
- genome wide analysis
- risk assessment
- spinal cord injury
- physical activity
- combination therapy
- human health
- health promotion